Track topics on Twitter Track topics that are important to you
Expands MS Pharma's geographic footprint, and complements its existing chronic disease portfolio
Original Article: MS Pharma Acquires GenepharmNEXT ARTICLE
Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...